![Dong Song Wei](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Dong Song Wei
Secretario Corporativo en SHANGHAI SHYNDEC PHARMACEUTICAL CO., LTD. .
Fortuna: 29 397 $ al 30/06/2024
Cargos activos de Dong Song Wei
Empresas | Cargo | Inicio | Fin |
---|---|---|---|
SHANGHAI SHYNDEC PHARMACEUTICAL CO., LTD. | Secretario Corporativo | 09/01/2012 | - |
Corporate Officer/Principal | 18/08/2011 | 09/01/2012 | |
Sinopharm YiXin Pharmaceutical Co., Ltd.
![]() Sinopharm YiXin Pharmaceutical Co., Ltd. Pharmaceuticals: MajorHealth Technology Sinopharm Holding A-Think Pharmaceutical Co., Ltd. engages in the manufacture and sale of injection mannose peptide. Its products and services include Octreotide acetate injection, Adenosine monophosphate for injection, Leucovorin for injection, Ondansetron hydrochloride injection, Sodium norcantharidin for injection, Norcantharidin tablet, Total saponin of ginseng stem and leaf tablets, Ginseng stems and leaves total saponin capsules, Vinorelbine tartaric acid for injection, and Poly-long-acting anti-bacterial membrane liquid material. The company was founded on December 10, 1997 and is headquartered in Changchun, China. | Director/Miembro de la Junta | - | - |
Historial de carrera de Dong Song Wei
Estadísticas
Internacional
China | 3 |
Operativa
Corporate Officer/Principal | 1 |
Corporate Secretary | 1 |
Director/Board Member | 1 |
Sectorial
Health Technology | 3 |
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
Empresas cotizadas | 1 |
---|---|
SHANGHAI SHYNDEC PHARMACEUTICAL CO., LTD. | Health Technology |
Empresas privadas | 1 |
---|---|
Sinopharm YiXin Pharmaceutical Co., Ltd.
![]() Sinopharm YiXin Pharmaceutical Co., Ltd. Pharmaceuticals: MajorHealth Technology Sinopharm Holding A-Think Pharmaceutical Co., Ltd. engages in the manufacture and sale of injection mannose peptide. Its products and services include Octreotide acetate injection, Adenosine monophosphate for injection, Leucovorin for injection, Ondansetron hydrochloride injection, Sodium norcantharidin for injection, Norcantharidin tablet, Total saponin of ginseng stem and leaf tablets, Ginseng stems and leaves total saponin capsules, Vinorelbine tartaric acid for injection, and Poly-long-acting anti-bacterial membrane liquid material. The company was founded on December 10, 1997 and is headquartered in Changchun, China. | Health Technology |
- Bolsa de valores
- Insiders
- Dong Song Wei
- Experiencia